Amplification of the ABL gene in T-cell acute lymphoblastic leukemia.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed, 54 citations in OpenAlex.

1. Developing Targeted Therapies for T Cell Acute Lymphoblastic Leukemia/Lymphoma.Current hematologic malignancy reports · 2023
   Review
2. Detection ofBlood research · 2022
   Article
3. Ring chromosome 7 in a child with T-cell acute lymphoblastic leukemia with myeloid markers.Proceedings (Baylor University. Medical Center) · 2021
   Article
4. Philadelphia chromosome positive pre-T cell acute lymphoblastic leukemia: a rare case report and short review.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2014
   Article
5. Diagnosis and subclassification of acute lymphoblastic leukemia.Mediterranean journal of hematology and infectious diseases · 2014
   Review
6. Six cases of rare gene amplifications and multiple copy of fusion gene in childhood acute lymphoblastic leukemia.Pathology oncology research : POR · 2013
   Article
7. Genetic aberrations in childhood acute lymphoblastic leukaemia: application of high-density single nucleotide polymorphism array.The Malaysian journal of medical sciences : MJMS · 2010
   Article
8. Cytogenetics and molecular genetics of acute lymphoblastic leukemia.Hematology/oncology clinics of North America · 2009
   Review
9. Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia.Leukemia · 2009
   Article
10. Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia.Leukemia · 2009
    Article
11. Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies.Leukemia · 2008
    Article
12. Transition from EML1-ABL1 to NUP214-ABL1 positivity in a patient with acute T-lymphoblastic leukemia.Leukemia · 2006
    Article
13. Chronic myeloproliferative disorders: a tyrosine kinase tale.Leukemia · 2006
    Review
14. The Eighth International Childhood Acute Lymphoblastic Leukemia Workshop ('Ponte di legno meeting') report: Vienna, Austria, April 27-28, 2005.Leukemia · 2006
    Article
15. Molecular cytogenetics in haematological malignancy: current technology and future prospects.Chromosoma · 2005
    Review
16. Fusion of NUP214 to ABL1 on amplified episomes in T-ALL--implications for treatment.Leukemia · 2005
    Article
17. A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemias.Leukemia · 2005
    Article
18. NUP214-ABL1 amplification in t(5;14)/HOX11L2-positive ALL present with several forms and may have a prognostic significance.Leukemia · 2005
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

15 authors at 6 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as